Reply to: Challenges to identifying risk versus protective factors in Alzheimer's disease
Juan Fortea,Lídia Vaqué-Alcázar,Jordi Pegueroles,Daniel Alcolea,Olivia Belbin,Oriol Dols-Icardo,Laura Videla,Juan Domingo Gispert,Marc Suárez-Calvet,Sterling C. Johnson,Reisa Sperling,Alexandre Bejanin,Alberto Lleó,Víctor Montal
DOI: https://doi.org/10.1038/s41591-024-03159-4
IF: 82.9
2024-07-18
Nature Medicine
Abstract:replying to C. Pappalettera et al. Nat. Med. https://doi.org/10.1038/s41591-024-03158-5 (2024) Pappalettera et al. 1 raise important points concerning our recent publication on APOE4 homozygotes 2 , specifically about the definition of Alzheimer's disease (AD), resilience factors, and the ethical implications of diagnosing asymptomatic individuals. We welcome the opportunity to clarify these points, emphasizing that APOE4 homozygotes represent one of the more frequent Mendelian diseases with incomplete clinical penetrance. We discuss critical points for future research to enable genetic counseling and personalized medicine.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?